Mark Bachleda
2022
In 2022, Mark Bachleda earned a total compensation of $788.6K as Chief Commercial Officer at Galera Therapeutics, a 39% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $172,900 |
|---|---|
| Option Awards | $128,526 |
| Salary | $475,000 |
| Other | $12,200 |
| Total | $788,626 |
Bachleda received $475K in salary, accounting for 60% of the total pay in 2022.
Bachleda also received $172.9K in non-equity incentive plan, $128.5K in option awards and $12.2K in other compensation.
Rankings
In 2022, Mark Bachleda's compensation ranked 3,538th out of 5,760 executives tracked by ExecPay. In other words, Bachleda earned more than 38.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,538 out of 5,760 | 39th |
Division Manufacturing | 2,007 out of 3,136 | 36th |
Major group Chemicals And Allied Products | 958 out of 1,422 | 33rd |
Industry group Drugs | 896 out of 1,323 | 32nd |
Industry Pharmaceutical Preparations | 653 out of 969 | 33rd |
Source: SEC filing on April 27, 2023.
Bachleda's colleagues
We found three more compensation records of executives who worked with Mark Bachleda at Galera Therapeutics in 2022.